WASHINGTON, Aug. 1 /PRNewswire/ -- Jim Greenwood, president and CEO of
the Biotechnology Industry Organization (BIO), released a statement today
encouraging the U.S. Senate to swiftly confirm Dr. Andrew von Eschenbach as
commissioner of the Food and Drug Administration (FDA).
"Dr. Andrew von Eschenbach is an outstanding choice to serve as
commissioner of the FDA. He will provide strong, certain leadership to this
critical agency that protects our nation's public health.
"Dr. von Eschenbach's experience as a cancer surgeon and his leadership
as director of the National Cancer Institute afford him unique insights
into the critical need to advance new treatments for patients with
life-threatening illnesses. As a teacher and academician, he appreciates
the importance of education and research in achieving scientific
breakthroughs.
"To provide safe and effective therapies for patients, and healthful
foods for consumers, the country needs a confirmed FDA commissioner to
ensure this agency is credible, predictable, and effective in protecting
the public health.
"I applaud President George W. Bush for his selection of Dr. von
Eschenbach, and I urge the Senate to move swiftly in the confirmation
process."
BIO represents more than 1,100 biotechnology companies, academic
institutions, state biotechnology centers and related organizations across
the United States and 31 other nations. BIO members are involved in the
research and development of healthcare, agricultural, industrial and
environmental biotechnology products.
SOURCE Biotechnology Industry Organization
 back to top
Related links:
http://www.bio.org
CONTACT:
Kim Coghill of Biotechnology Industry
Organization, +1-202-962-9232
|
